ARG1 and metabolic disease: In humans and rodents with inflammatory bowel disease, contrasting the findings in settings of metabolic disease, arginase-1 expression in intestinal tissue was reported to be induced and a genetic deletion of arginase-1 in immune cells was reported to arbitrate a significant protection against intestinal inflammation [55].